Endocrinology · Electrolyte Disorders
The facts most likely to be tested
Refeeding syndrome is the most common cause of severe hypophosphatemia in hospitalized patients due to a massive intracellular shift of phosphate during insulin-stimulated glucose uptake.
Severe hypophosphatemia manifests as diaphragmatic weakness, respiratory failure, and rhabdomyolysis due to profound ATP depletion.
Chronic hypophosphatemia leads to osteomalacia in adults and rickets in children due to impaired bone mineralization.
Alcohol use disorder is a classic risk factor for hypophosphatemia caused by poor nutritional intake, magnesium deficiency, and increased urinary phosphate excretion.
Fanconi syndrome causes hypophosphatemia through proximal renal tubular acidosis leading to excessive urinary phosphate wasting.
Hyperparathyroidism induces hypophosphatemia by increasing renal phosphate excretion via the inhibition of sodium-phosphate cotransporters in the proximal tubule.
Treatment of severe, symptomatic hypophosphatemia requires intravenous phosphate replacement with careful monitoring for hypocalcemia and metastatic calcification.
Vignette unlocked
A 42-year-old male with a history of severe alcohol use disorder is admitted for malnutrition. On day 3 of hospitalization, he is started on aggressive enteral nutrition. He subsequently develops shallow respirations, generalized muscle weakness, and elevated creatine kinase. Laboratory studies reveal a serum phosphate level of 0.8 mg/dL.
What is the most likely underlying pathophysiology of this patient's condition?
Intracellular shift of phosphate due to insulin-stimulated glucose uptake
The patient is experiencing refeeding syndrome, where the introduction of carbohydrates triggers an insulin surge that drives phosphate into cells, causing severe hypophosphatemia and subsequent respiratory and muscular failure.
Full handout
High yield triage
Etiology / Epidemiology
Common in alcohol use disorder, refeeding syndrome, and diabetic ketoacidosis. Driven by intracellular shifts or renal wasting.
Clinical Manifestations
Severe cases present with muscle weakness, rhabdomyolysis, and respiratory failure. Watch for myocardial dysfunction.
Diagnosis
Serum phosphate < 2.5 mg/dL is diagnostic. Serum phosphate level is the gold standard.
Treatment
Oral potassium phosphate for mild cases; IV phosphate for severe cases with caution for hypocalcemia.
Prognosis
Severe depletion (< 1.0 mg/dL) carries high risk of arrhythmias and death if untreated.
Full handout
Epidemiology & Etiology
Prevalent in hospitalized patients, particularly those with malnutrition or alcoholism. Often triggered by rapid insulin administration causing intracellular phosphate shifts. Chronic cases are frequently linked to hyperparathyroidism or renal tubular defects.
Pertinent Anatomy
The kidneys are the primary regulators of phosphate via the proximal convoluted tubule. Phosphate is essential for the structural integrity of the sarcolemma and myocardial fibers.
Pathophysiology
Phosphate is a critical component of ATP and 2,3-DPG. Depletion leads to impaired oxygen delivery to tissues and cellular energy failure. This manifests as systemic dysfunction, particularly in high-energy tissues like the diaphragm and myocardium.
Clinical Manifestations
Patients may exhibit paresthesias, ataxia, and seizures in extreme depletion. Respiratory failure due to diaphragmatic weakness is a life-threatening emergency. Chronic deficiency leads to osteomalacia and bone pain.
Diagnosis
Diagnosis is confirmed by a serum phosphate level < 2.5 mg/dL. Severe hypophosphatemia is defined as < 1.0 mg/dL. Always check serum calcium and magnesium concurrently, as they are often depleted.
Treatment
Asymptomatic patients with levels > 1.0 mg/dL receive oral potassium phosphate. Symptomatic or severe cases require IV phosphate infusion. Avoid rapid IV infusion to prevent metastatic calcification and hypocalcemia.
Prognosis
Recovery is typically rapid with appropriate replacement. Cardiac arrhythmias and respiratory arrest are the primary causes of mortality. Monitor serum electrolytes every 6-12 hours during aggressive repletion.
Differential Diagnosis
Refeeding Syndrome: associated with rapid carbohydrate intake in starved patients
Hyperparathyroidism: characterized by hypercalcemia and elevated PTH
Fanconi Syndrome: associated with glycosuria and aminoaciduria
Diabetic Ketoacidosis: total body depletion masked by initial extracellular shifts
Respiratory Alkalosis: causes intracellular phosphate shift without total body depletion